Secondary outcome measures

DU Devica S Umans
HT Hester C Timmerhuis
NH Nora D Hallensleben
SB Stefan A Bouwense
MA Marie-Paule GF Anten
AB Abha Bhalla
RB Rina A Bijlsma
MB Marja A Boermeester
MB Menno A Brink
LH Lieke Hol
MB Marco J Bruno
WC Wouter L Curvers
HD Hendrik M van Dullemen
BE Brechje C van Eijck
GE G Willemien Erkelens
PF Paul Fockens
EG Erwin J M van Geenen
WH Wouter L Hazen
CH Chantal V Hoge
AI Akin Inderson
LK Liesbeth M Kager
SK Sjoerd D Kuiken
LP Lars E Perk
JP Jan-Werner Poley
RQ Rutger Quispel
TR Tessa EH Römkens
HS Hjalmar C van Santvoort
AT Adriaan CITL Tan
AT Annemieke Y Thijssen
NV Niels G Venneman
FV Frank P Vleggaar
AV Annet MCJ Voorburg
RW Roy LJ van Wanrooij
BW Ben J Witteman
RV Robert C Verdonk
MB Marc G Besselink
JH Jeanin E van Hooft
request Request a Protocol
ask Ask a question
Favorite

The secondary outcome measures are recurrence rate of acute pancreatitis, severity of recurrent pancreatitis,20 readmission, performance of additional invasive procedures (eg, cholecystectomy, endoscopic sphincterotomy), complications of EUS and of additional interventions, according to the Clavien-Dindo classification,24 length of hospital stay, quality of life, mortality and costs. Relevant definitions are reported in online supplementary additional file 2.

bmjopen-2019-035504supp002.pdf

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A